COMPLETED

Light, Metabolic Syndrome and Alzheimer's Disease - Aim 2

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To test the long term effect of a light treatment on cognition, sleep and metabolism in patients with Mild cognitive impairment (MCI) or mild Alzheimer's disease or related dementia (ADRD).

Official Title

Light, Metabolic Syndrome and Alzheimer's Disease: A Non-Pharmocological Approach

Quick Facts

Study Start:2019-01-02
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:COMPLETED

Study ID

NCT03933696

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Mild cognitive impairment
  2. * Mild Alzheimer's Disease
  3. * Sleep Disturbance
  4. * Live at home
  1. * Blindness
  2. * insulin-dependent diabetes patients
  3. * macular degeneration
  4. * severe sleep apnea

Contacts and Locations

Principal Investigator

Mariana G Figueiro, PhD
PRINCIPAL_INVESTIGATOR
Icahn School of Medicine at Mount Sinai

Study Locations (Sites)

Rutgers University
New Brunswick, New Jersey, 08854
United States
Icahn School of Medicine at Mount Sinai
New York, New York, 10029
United States

Collaborators and Investigators

Sponsor: Icahn School of Medicine at Mount Sinai

  • Mariana G Figueiro, PhD, PRINCIPAL_INVESTIGATOR, Icahn School of Medicine at Mount Sinai

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-01-02
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2019-01-02
Study Completion Date2025-05-31

Terms related to this study

Additional Relevant MeSH Terms

  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Type2 Diabetes